Back to Journals » OncoTargets and Therapy » Volume 9
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,811 | Dovepress* | 7,134+ | 1,307 | 8,441 | |
PubMed Central* | 1,677 | 295 | 1,972 | ||
Totals | 8,811 | 1,602 | 10,413 | ||
*Since 16 September 2016 |
View citations on PubMed and Google Scholar